HSC01
clear graphic
clear graphic

Register now for the Vulcan Funshoot benefiting CTRC

Posted: Tuesday, August 21, 2012 · Volume: XLV · Issue: 17

Share |


The Vulcan Funshoot Sept. 8 gives sporting-clay enthusiasts a fun way to help raise funds for the Cancer Therapy & Research Center at the UT Health Science Center San Antonio. For more information about the event, call 210-524-3515.
clear graphic
The Vulcan Funshoot Sept. 8 gives sporting-clay enthusiasts a fun way to help raise funds for the Cancer Therapy & Research Center at the UT Health Science Center San Antonio. For more information about the event, call 210-524-3515. clear graphic

Email Printer Friendly Format
 

Contact: Catherine Duncan, 210-567-2570

SAN ANTONIO (Aug. 14, 2012) — Registration is under way for the 19th annual Vulcan Materials Funshoot, a sporting-clay competition benefiting the Cancer Therapy & Research Center (CTRC) at the UT Health Science Center San Antonio.

The competition will be held on Saturday, Sept. 8, at the National Shooting Complex, 5931 Roft Road, off Culebra Road and outside Loop 1604.

Individuals can sign up to shoot for $350 per person. Sponsorships are available at three levels, with all sponsorships including a team of five shooters. Sponsor levels are platinum at $5,000, diamond at $2,500 and gold at $1,500. Businesses and individuals also can donate items for the silent and live auctions.

In the past 18 years, Vulcan Materials has raised more than $1.7 million to support the CTRC’s mission to conquer cancer through research, prevention and treatment.

To register and for sponsorship information, call Vulcan Materials Company at 210-524-3515.

# # #

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI)-designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.

 
bottom bar

»printer friendly format...
»view more articles by issue#...
»search articles by keywords...
Arrow - to top
HSC Alert - Sign up today
Calendar of Events
Tell Us Your Story Idea
Submission Guidelines
Arrow - to top